Houses of the Oireachtas

All parliamentary debates are now being published on our new website. The publication of debates on this website will cease in December 2018.

Go to oireachtas.ie

McGrath, Finian

Monday, 17 December 2012

Dáil Éireann Debate
Vol. Nbr.


Health (Pricing and Supply of Medical Goods) Bill 2012 [Seanad]: Second Stage (Resumed) (Continued)

I thank you, a Leas-Cheann Comhairle, for the opportunity to speak on the Health (Pricing and Supply of Medical Goods) Bill 2012. This is an important Bill and it is also important to develop the ...More Button

That company employs 4,000 people in this sector, a massive economic contribution to the State. I consider myself to be on the left but I agree with colleagues that the 12.5% corporation is the se...More Button

Mr. Gallagher, the managing director of Pfizer Ireland, said that the company is not a charity and that it invests where it believes it will get a return; it is as simple as that and there is no ...More Button

There is a conflict of interest but there is no reason we cannot deal with this issue. When Mr. Gallagher says Pfizer Ireland is not a charity, that is fair enough but we have a different philos...More Button

These groups must be around the table, I accept that, they provide jobs to Irish people and pay corporation tax, but I worry we might be losing the balance in the debate about the respite care gr...More Button

The figures for expenditure on medicines and non-drug items are huge. In 2011, the HSE expenditure on medicines and non-drug items such as dressings supplied to patients in the community was app...More Button

Savings have been achieved through the ongoing off-patent price cuts agreed with the pharmaceutical manufacturers and we welcome that. The Department and the HSE continue to engage with the Iris...More Button

In July 2009, the wholesale mark-up paid on medicines was reduced from 17.66% to 10%, a sliding dispensing fee was introduced and the retail mark-up paid under the drug payment scheme. The long-...More Button

In June 2011, regulations were made to reduce certain payments by the HSE to the community pharmacy contractors, which included a reduction from 10% to 8% in the wholesale price mark-up of drugs ...More Button

The reaction of the IMO to this legislation is important. It has stated it welcomes the proposals for reference pricing but would not include the maximum potential saving on its own. It stated ...More Button

In addition the Irish Medical Organisation, IMO, has suggested that current policies for setting generic prices are not optimal and it has argued for the promotion of more competition as a means of...More Button

The organisation has called for the Irish Medicines Board to ensure regulation does not unduly discourage the entry of safe generic medicines to the market. This is something I referred to earli...More Button

The IMO also proposes transparency in the distribution chain and has called for the regulation of margins. It has highlighted several important and relevant aspects of the legislation and the ne...More Button

The Irish Pharmacy Union, IPU, is the representative organisation for community pharmacists in Ireland. It has broadly welcomed the plans to enable pharmacists to dispense cheaper generic drugs ...More Button

The final group which we must consider is made up of patients groups and patient advocate groups. Their concerns have centred on the question of whether medicines are genuinely interchangeable f...More Button

I welcome the broader debate. We all seek efficiency and cost savings on drugs in the State because it is a significant issue. I noted earlier in my introduction that it was important to get th...More Button